Focus Stocks
Altera Near the 200 Day
Published on Thursday, 09 February 2012 06:36 Written by TradersHuddle Wire
New York, February 9th (TradersHuddle.com) - Shares of Altera Corporation (NASDAQ:ALTR) traded at $40.77 close to its 200 day moving average currently set at $39.61. Altera's price action is just above this key support level, and it will certainly raise traders attention, as a possible trading opportunity.
Altera Corporation (NASDAQ:ALTR) designs, manufactures, and markets programmable logic devices and associated development tools. The Company's products, include a variety of programmable logic devices and hardcopy application-specific integrated circuits. Altera serves customers primarily in the communications, computer and storage, industrial, and consumer sectors
Latest price action range, defined by a peaks and troughs algorithm places calculated support at $38.27 and calculated resistance at $41.32. These levels will certainly be watched by traders, as they provide insight into the latest price dynamics defined by Altera stock.
Traders wanting to establish a position on Altera will be looking at the price action for evidence of buying near the 200 day moving average, and opening a position as close as possible to this important level. Also traders will be looking at the latest price action, via the stocks current range previously defined for insights of other key levels that might affect their upside or downside.
Related Articles
- Altera near Support
- Sector Wrap - Semis Lower: CREE, NVDA, POWI
- Altera Broke Support
- Up/Downgrades
- Trading Idea: Is Altera close to Support?
- Trading Idea: Entry Levels for Altera
- Dow Jumps for the Week on Robust Earnings
- Cree - Top Performer Semiconductor
- NASDAQ 100 Round Up - Higher: MSFT, STX, NWSA
Related Partner Headlines
- Altera Corp. (ALTR): Today's Featured Technology Winner - TheStreet.com
- Altera Stock To Go Ex-dividend Tomorrow (ALTR) - TheStreet.com
- Stock Gain on February Jobs Data - TheStreet.com
- Stocks to Watch: Starbucks, TI, Altera - TheStreet.com
- Altera Sees 5-9% Sequential Revenue Decline in Q1 - Benzinga
- SemiAccurate: TSMC Suddenly Halts 28nm Production; Potentially Negative for NVDA, QCOM, ALTR, XLNX - Benzinga
- Altera Stock To Go Ex-dividend Tomorrow (ALTR) - TheStreet.com
- Analysts' Actions: RIMM, SIRI, ALTR AMGN, HD - TheStreet.com
- Texas Instruments Beats Intel, JPMorgan Says - TheStreet.com
- Altera, Cavium: After-Hours Trading - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









